Tag Archives: anti-arrhythmic drugs
August 2012 Br J Cardiol 2012;19:122–3 doi:10.5837/bjc.2012.020
Translating regulatory advice into practice: use of dronedarone and older anti-arrhythmics in AF management
A consensus position statement. A John Camm, Chris Arden, Anna-Maria Choy, Riyaz A Kaba, David Keane, Khalid Khan, Ernest Lau, Gregory Y H Lip, Francis Murgatroyd, G Andre Ng, Nicholas Peters, Henry Purcell, Peter Stafford, Neil Sulke, Helen Williams
Introduction Patients with atrial fibrillation (AF) can benefit from rhythm management to improve unpleasant symptoms or increase exercise capacity,1 making anti-arrhythmic drugs (AADs) an important option in the management of AF. The benefits of any AAD must be weighed against the risks of adverse effects, which in some cases are serious. Defined indications for the use of AADs have been developed by regulatory bodies such as the European Medicines Agency (EMA) and US Food and Drug Administration (FDA), which, in addition to guidelines from groups such as the UK National Institute for Health and Clinical Excellence (NICE) and the European So
April 2011 Br J Cardiol 2011;18:88−93
Public perception of atrial fibrillation and treatment-related adverse events in the UK
Scott Doyle, Andrew Lloyd, Mark Davis
Introduction Atrial fibrillation (AF) is a common cardiac arrhythmia affecting approximately six million patients in Europe and 2.3 million in the USA.1 Estimates in the general population suggest a prevalence rate of 0.4–1.0%, with marked increase in prevalence with age, increasing to approximately 10% by the age of 80 years.2 AF can precipitate heart failure, ventricular arrhythmias, and it is associated with a four- to five-fold increase in chance of stroke.3,4 In addition, although AF is frequently asymptomatic, it can reduce quality of life causing fatigue, palpitations, anxiety and dizziness.3 AF is classified in three ways:5 Paroxy
September 2003 Br J Cardiol 2003;10:329-31
Cardiology and the new GMS contract for GPs
Mike Mead
No content available
For healthcare professionals only
